Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
asthma
Pharma
AstraZeneca caps out-of-pocket inhaler costs at $35 in the US
At a critical moment for the U.S. inhaler market, AstraZeneca is following its peer Boehringer Ingelheim and taking a step to boost patient access.
Fraiser Kansteiner
Mar 18, 2024 11:02am
Boehringer cuts out-of-pocket inhaler prices to $35 in US
Mar 7, 2024 11:10am
GSK's asthma inhaler market pull draws Warren's ire
Mar 5, 2024 10:57am
NY attorney general wants FDA to tweak Singulair's safety label
Feb 27, 2024 9:25am
FDA approves Roche, Novartis' Xolair for common food allergies
Feb 16, 2024 2:28pm
GSK aims to slash carbon emissions with next-generation inhaler
Nov 21, 2023 10:16am